Suppr超能文献

巨噬细胞胆固醇代谢的数量性状基因座定位及 CRISPR/Cas9 编辑提示 ACAT1 截断是一种因果修饰变体。

Quantitative Trait Locus Mapping of Macrophage Cholesterol Metabolism and CRISPR/Cas9 Editing Implicate an ACAT1 Truncation as a Causal Modifier Variant.

机构信息

From the Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Henan, China (Q.H., J.Z.); Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland, OH (Q.H., B.R., P.R., A.M.A., G.B., J.D.S); and Department of Chemistry, Cleveland State University, OH (B.R.).

出版信息

Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):83-91. doi: 10.1161/ATVBAHA.117.310173. Epub 2017 Nov 2.

Abstract

OBJECTIVE

Cholesterol metabolism is a dynamic process involving intracellular trafficking, cholesterol esterification, and cholesterol ester hydrolysis. Our objective was to identify genes that regulate macrophage cholesterol metabolism.

APPROACHES AND RESULTS

We performed quantitative trait loci mapping of free and esterified cholesterol levels and the ratio of esterified to free cholesterol in acetylated low-density lipoprotein-loaded bone marrow-derived macrophages from an AKR×DBA/2 strain intercross. Ten distinct cholesterol modifier loci were identified, and bioinformatics was used to prioritize candidate genes. The strongest locus was located on distal chromosome 1, which we named (macrophage cholesterol metabolism modifier 1). This locus harbors the (sterol O-acyltransferase 1) gene, encoding Acyl-coenzyme A:cholesterol acyltransferase 1 (ACAT1), which esterifies free cholesterol. The parental AKR strain has an exon 2 deletion in Soat1, which leads to a 33 amino acid N-terminal truncation in ACAT1. CRISPR/Cas9 editing of DBA/2 embryonic stem cells was performed to replicate the AKR strain Soat1 exon 2 deletion, while leaving the remainder of the genome unaltered. DBA/2 stem cells and stem cells heterozygous and homozygous for the Soat1 exon 2 deletion were differentiated into macrophages and loaded with acetylated low-density lipoprotein. DBA/2 stem cell-derived macrophages accumulated less free cholesterol and more esterified cholesterol relative to cells heterozygous and homozygous for the Soat1 exon 2 deletion.

CONCLUSIONS

A Soat1 deletion present in AKR mice, and resultant N-terminal ACAT1 truncation, was confirmed to be a significant modifier of macrophage cholesterol metabolism. Other Mcmm loci candidate genes were prioritized via bioinformatics.

摘要

目的

胆固醇代谢是一个涉及细胞内运输、胆固醇酯化和胆固醇酯水解的动态过程。我们的目的是鉴定调节巨噬细胞胆固醇代谢的基因。

方法和结果

我们对载有乙酰化低密度脂蛋白的骨髓来源巨噬细胞中的游离胆固醇和酯化胆固醇水平以及酯化胆固醇与游离胆固醇的比值进行了 AKR×DBA/2 品系杂交的数量性状基因座作图。鉴定出 10 个不同的胆固醇修饰基因座,并用生物信息学方法对候选基因进行了优先级排序。最强的基因座位于远端染色体 1 上,我们将其命名为 (巨噬细胞胆固醇代谢修饰 1)。该基因座包含编码酰基辅酶 A:胆固醇酰基转移酶 1(ACAT1)的 (甾醇 O-酰基转移酶 1)基因,该酶将游离胆固醇酯化。亲代 AKR 品系的 Soat1 基因外显子 2 缺失,导致 ACAT1 的 N 端 33 个氨基酸缺失。通过 CRISPR/Cas9 编辑 DBA/2 胚胎干细胞,模拟 AKR 品系 Soat1 外显子 2 缺失,而不改变基因组的其余部分。DBA/2 干细胞及其 Soat1 外显子 2 缺失杂合和纯合的干细胞分化为巨噬细胞,并加载乙酰化低密度脂蛋白。与 Soat1 外显子 2 缺失杂合和纯合的细胞相比,DBA/2 干细胞衍生的巨噬细胞积累的游离胆固醇减少,酯化胆固醇增加。

结论

在 AKR 小鼠中存在的 Soat1 缺失,以及由此产生的 ACAT1 N 端截断,被证实是巨噬细胞胆固醇代谢的重要修饰因子。其他 Mcmm 基因座候选基因通过生物信息学进行了优先级排序。

相似文献

8
ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease.ACAT1/SOAT1作为阿尔茨海默病的治疗靶点。
Future Med Chem. 2015;7(18):2451-67. doi: 10.4155/fmc.15.161. Epub 2015 Dec 15.

引用本文的文献

3
Gene editing therapy for cardiovascular diseases.心血管疾病的基因编辑疗法
MedComm (2020). 2024 Jul 5;5(7):e639. doi: 10.1002/mco2.639. eCollection 2024 Jul.

本文引用的文献

4
ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease.ACAT1/SOAT1作为阿尔茨海默病的治疗靶点。
Future Med Chem. 2015;7(18):2451-67. doi: 10.4155/fmc.15.161. Epub 2015 Dec 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验